Medical Science Liaison Roles: Enigma and Dilemma
Second (Winter 2009) update of “Medical Science Liaison: Examining the Role, Revisited” by Jane Chin PhD, originally published in Medical Science Liaison Quarterly, Volume I Number 4, Winter 2004. Supersedes update published in Fall 2006.
“This article remains as pertinent as ever for MSL directors to read and re-read especially considering the repercussions of the 2009 PhRMA code. Compliance officers should make this a required reading.” MSL Director, Specialty Pharmaceutical Company.
MEDICAL SCIENCE LIAISON ROLES: ENIGMA AND DILEMMA 3
Introduction 3
A Medical Science Liaison on National TV 3
Moment of Truth Assessment for MSL Directors 4
Intent of Field-Medical Involvement 4
Reach and Frequency Directives 5
Whose Quota are These, Anyway? 5
Why MSL Roles Remain an Enigma 6
Lack of Guidance Driven by Industry and Governing Bodies 7
How “Safe” is Organizing MSL Programs Under Medical Affairs? 7
MSL Role: Substantive or Symbolic? 9
Expanding MSL Programs: Encouraging or Concerning? 9
A Matter of Culture and Self Examination 11
8.25×10.75″ 12 pages.
Print Magazine: Please allow 3-5 business days to ship within US (product is shipped from California). Print magazines are meant for personal use and should not be reproduced, copied, or distributed.
For internal distribution, training, or project/consulting use, please purchase PDF license.
Branded PDF (MULTI-USER): Please allow 2-24 hours for delivery, and is meant for up to 10 authorized users and will be shipped to the billing email address used in your payment. For additional users or legal use / upload within your company’s corporate intranet, please contact us at info@msliq.com or phone 1 (310) 542-5642.
